David Fleischer, MD: Phase 3 Trial on Peanut Immunotherapy Patch
In his interview, Fleischer discussed the beginning of a new phase 3 trial for a peanut immunotherapy patch known as DBV712.
Source: hcplive.com
Stay updated with breaking news from Evaluate Safety Simplicity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In his interview, Fleischer discussed the beginning of a new phase 3 trial for a peanut immunotherapy patch known as DBV712.
In this interview segment, Fleischer further described some of the key points about the peanut immunotherapy patch, DBV712, and the product’s phase 3 VITESSE trial.